
CareCloud, Inc. (NASDAQ:CCLD – Free Report) – Stock analysts at Maxim Group upped their Q2 2027 EPS estimates for shares of CareCloud in a research note issued on Thursday, November 5th. Maxim Group analyst A. Klee now expects that the company will earn $0.12 per share for the quarter, up from their previous forecast of $0.10. The consensus estimate for CareCloud’s current full-year earnings is $0.22 per share. Maxim Group also issued estimates for CareCloud’s Q4 2027 earnings at $0.10 EPS, Q1 2028 earnings at $0.06 EPS, Q2 2028 earnings at $0.14 EPS, Q3 2028 earnings at $0.18 EPS and FY2028 earnings at $0.51 EPS.
CareCloud (NASDAQ:CCLD – Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.04. CareCloud had a net margin of 6.21% and a return on equity of 27.07%. The firm had revenue of $33.73 million during the quarter, compared to analysts’ expectations of $33.50 million.
A number of other brokerages have also weighed in on CCLD. Weiss Ratings raised shares of CareCloud from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, October 12th. Wall Street Zen upgraded shares of CareCloud from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Finally, Roth Capital dropped coverage on CareCloud in a report on Tuesday, September 15th. They set a “neutral” rating on the stock. Prior estimates, ratings, and price targets should no longer be relied upon. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, CareCloud presently has an average rating of “Moderate Buy”.
Get Our Latest Analysis on CCLD
CareCloud Price Performance
Shares of CCLD stock opened at $2.51 on Tuesday. CareCloud has a 1 year low of $1.67 and a 1 year high of $3.81. The firm’s 50 day moving average is $2.01 and its 200-day moving average is $2.46. The firm has a market capitalization of $106.65 million, a price-to-earnings ratio of 19.31 and a beta of 1.57. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 2.20.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC increased its holdings in CareCloud by 5.9% in the first quarter. Renaissance Technologies LLC now owns 472,300 shares of the company’s stock valued at $1,724,000 after purchasing an additional 26,270 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in CareCloud by 49.7% during the first quarter. Dimensional Fund Advisors LP now owns 377,567 shares of the company’s stock worth $1,377,000 after buying an additional 125,435 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in CareCloud during the first quarter worth about $920,000. Sei Investments Co. grew its position in shares of CareCloud by 110.2% during the 1st quarter. Sei Investments Co. now owns 228,358 shares of the company’s stock worth $834,000 after buying an additional 119,705 shares during the period. Finally, Globeflex Capital L P acquired a new position in shares of CareCloud during the 2nd quarter worth about $711,000. 10.16% of the stock is currently owned by institutional investors.
About CareCloud
CareCloud, Inc (NASDAQ: CCLD) provides cloud-based health care information technology and revenue cycle management services to medical practices, hospitals and other health care organizations. The company’s solutions are designed to help providers manage administrative, clinical and financial operations through integrated software and technology-enabled services.
Its offerings include electronic health records, practice management, medical billing and revenue cycle management, patient engagement tools, telehealth capabilities and related health care technology services.
Featured Stories
- Five stocks we like better than CareCloud
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.
